Repatha® (evolocumab) – New formulation approval
July 11, 2016 – Amgen announced the FDA approval of Repatha (evolocumab) Pushtronex™ system (on-body infusor with prefilled cartridge), a hands-free device that delivers 420 mg of Repatha in a single-dose.
Download PDF
